Zobrazeno 1 - 10
of 239
pro vyhledávání: '"Masumi Kadoya"'
Autor:
Hideki Nagano, Shigekazu Ohyama, Atsushi Sato, Jun Igarashi, Tomoko Yamamoto, Masumi Kadoya, Mikiko Kobayashi
Publikováno v:
Diagnostic Pathology, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background Neurofibromatosis type 1 (NF1) is known to be associated with the frequent occurrence of unique gastrointestinal stromal tumors (GISTs), preferably occurring in the small intestine, with no mutations in the c-kit proto-oncogene or
Externí odkaz:
https://doaj.org/article/9079a1b14dff4c70ae2826a2dfc6b9c7
Autor:
Hideki Nagano, Shigekazu Ohyama, Atsushi Sato, Jun Igarashi, Tomoko Yamamoto, Masumi Kadoya, Mikiko Kobayashi
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background Alteration of chemosensitivity or tumor aggressiveness in response to chemotherapy has been reported, and liquid biopsy assessment during chemotherapy for colorectal cancers has confirmed the acquisition of mutations in various on
Externí odkaz:
https://doaj.org/article/9025ef245ad74d7180419677e95c6286
Autor:
Shoji Kubo, Hiroji Shinkawa, Yoshinari Asaoka, Tatsuya Ioka, Hiroshi Igaki, Namiki Izumi, Takao Itoi, Michiaki Unno, Masayuki Ohtsuka, Takuji Okusaka, Masumi Kadoya, Masatoshi Kudo, Takashi Kumada, Norihiro Kokudo, Michiie Sakamoto, Yoshihiro Sakamoto, Hideyuki Sakurai, Tadatoshi Takayama, Osamu Nakashima, Yasushi Nagata, Etsuro Hatano, Kenichi Harada, Takamichi Murakami, Masakazu Yamamoto
Publikováno v:
Liver Cancer (2022)
This paper presents the first version of clinical practice guidelines for intrahepatic cholangiocarcinoma (ICC) established by the Liver Cancer Study Group of Japan. These guidelines consist of 1 treatment algorithm, 5 background statements, 16 clini
Externí odkaz:
https://doaj.org/article/d40c7cea31754bd5ae1f64e943bf3082
Autor:
Shoji Kubo, Hiroji Shinkawa, Yoshinari Asaoka, Tatsuya Ioka, Hiroshi Igaki, Namiki Izumi, Takao Itoi, Michiaki Unno, Masayuki Ohtsuka, Takuji Okusaka, Masumi Kadoya, Masatoshi Kudo, Takashi Kumada, Norihiro Kokudo, Michiie Sakamoto, Yoshihiro Sakamoto, Hideyuki Sakurai, Tadatoshi Takayama, Osamu Nakashima, Yasushi Nagata, Etsuro Hatano, Kenichi Harada, Takamichi Murakami, Masakazu Yamamoto
Publikováno v:
Liver cancer. 11(4)
This paper presents the first version of clinical practice guidelines for intrahepatic cholangiocarcinoma (ICC) established by the Liver Cancer Study Group of Japan. These guidelines consist of 1 treatment algorithm, 5 background statements, 16 clini
Autor:
Michiie Sakamoto, Norihiro Kokudo, Isao Yokota, Masatoshi Kudo, Yutaka Matsuyama, Masanori Kon, Kiyoshi Hasegawa, Shoji Kubo, Osamu Nakashima, Takashi Kumada, Masumi Kadoya, Kengo Yoshii, Fumio Nagashima, Namiki Izumi, Masaki Kaibori, Tadatoshi Takayama
Publikováno v:
Annals of Surgery. 269:692-699
The impact of age on survival after hepatic resection for hepatocellular carcinoma (HCC) has not been thoroughly examined. We reviewed the data of a nationwide follow-up survey to determine the outcomes of hepatectomy for HCC in elderly patients.Mana
Autor:
Norihiro Kokudo, Junko Tanaka, Kiyoshi Hasegawa, Yutaka Matsuyama, Yuji Kaneoka, Michiie Sakamoto, Yasuyuki Fukami, Tatsuya Yamashita, Masatoshi Kudo, Takashi Kumada, Tomoyuki Akita, Osamu Nakashima, Namiki Izumi, Tadatoshi Takayama, Masumi Kadoya, Shoji Kubo, Takashi Kokudo, Atsuyuki Maeda, Kosuke Kashiwabara
Publikováno v:
Annals of Surgery. 272:145-154
The aim of the study was to evaluate the survival benefits of liver resection (LR) compared with transarterial chemoembolization (TACE) for patients with multiple hepatocellular carcinomas (HCCs).Despite significant improvements in diagnostic imaging
Autor:
Atsushi Hiraoka, Yutaka Matsuyama, Susumu Eguchi, Osamu Nakashima, Namiki Izumi, Michiie Sakamoto, Tadatoshi Takayama, Masumi Kadoya, Takashi Kokudo, Masatoshi Kudo, Shoji Kubo, Takashi Kumada, Tatsuya Yamashita, Kojiro Michitaka, Kosuke Kashiwabara, Norihiro Kokudo
Publikováno v:
Liver Cancer
Background/Aim: Adequate assessment of transcatheter arterial chemoembolization (TACE)-refractory status has become more important for switching treatment in intermediate-stage (BCLC-B) hepatocellular carcinoma (HCC) patients treated with TACE. The u
Autor:
Masumi Kadoya, Kenji Notohara, Masaaki Takahashi, Toshifumi Gabata, Takashi Koyama, Hiroyuki Irie, Kazuichi Okazaki, Yasunari Fujinaga, Shigeyuki Kawa, Dai Inoue
Publikováno v:
Japanese journal of radiology. 38(7)
The International Consensus Diagnosis Criteria for autoimmune pancreatitis (AIP) has been published internationally for the diagnosis of AIP. However, since the revisions in 2006 and 2011, the Clinical Diagnostic Criteria for Autoimmune Pancreatitis
Autor:
Kazuhiko Ueda, Masumi Kadoya, Takeshi Suzuki, Daisuke Komatsu, Yasunari Fujinaga, Masahiro Kurozumi, Akira Yamada
Publikováno v:
Hepatology Research. 48:829-838
AIM To verify the utility of the 2-in-1-out-compartment model analysis (CMA) of intravenous contrast-enhanced dynamic computed tomography (IV-CT) for evaluating hepatic arterial and portal venous flow using intra-arterial contrast-enhanced CT (IA-CT)
Autor:
Yasunari Fujinaga, Daisuke Komatsu, Atsushi Nozaki, Yuji Iwadate, Yoshihiro Kitoh, Masumi Kadoya, Takeshi Suzuki, Kazuhiko Ueda, Akira Yamada
Publikováno v:
Hepatology Research. 48:735-745
AIM The purpose of this study was to determine whether the liver stiffness (LS) measured on magnetic resonance (MR) elastography can be estimated by a combination of gadoxetate disodium-enhanced MR imaging (EOB-MRI) and ordinary blood tests. METHODS